I would add Takeda that after merging with Shire it has become the world leader in rare diseases and is one of those that is most busy finding new opportunities to expand its already well-structured pipeline of diseases:
https://www.takeda.com/who-we-are/c...rldwide-offices/Takeda-China-Holdings-Co-Ltd/
https://www.takeda.com/4ab4a0/sitea...ansformation-to-deliver-more-for-patients.pdf
https://www.takeda.com/what-we-do/research-and-development/our-pipeline/
https://www.takeda.com/investors/financial-results-highlight-video/
China deal?, page-46
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.10 |
Change
-0.620(2.99%) |
Mkt cap ! $2.569B | |||
| Open | High | Low | Value | Volume |
| $20.41 | $20.45 | $19.92 | $5.947M | 296.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 999 | $20.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.19 | 10 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |